Until the end of 2003, Brenntag had been a stock corporation, before Bain Capital converted it into a limited liability company.

[5] After the takeover by BC Partners, Brenntag continued to acquire companies worldwide, expanding its network and market shares.

[4][12] Since 29 March 2010, Brenntag AG (WKN A1DAHH) is listed at the German Stock Exchange in the Prime Standard Segment, from 21 June 2010 until September 2021 as a member of the MDAX index.

[15] In 2010, Brenntag further expanded its market presence in the region significantly by acquiring EAC Industrial Ingredients Ltd. in Bangkok.

[10] In 2011, Brenntag established a joint venture with Zhong Yung International Chemical Ltd. in China and in 2016 the company acquired the distributor EPChem Group in Singapore.

[16][17] Due to capacity problems, in 2017, Brenntag moved its headquarters from Mülheim an der Ruhr, to the House of Elements in Essen-Rüttenscheid.

The shareholders subject to voting right notification are BlackRock (>5%), Capital Group Companies, Inc. (>5%), Ameriprise Financial, Inc. (>3%), Flossbach von Storch AG (>3%), Wellington Management Group (>3%), GIC Private Limited (>3%), Burgundy Asset Management (>3%), EuroPacific Growth Fund (>3%), Kühne Holding AG (>3%).

[23][24] Part of Brenntag's business strategy is the acquisition, i.e., buying companies to strengthen its own market position and expand its portfolio.

[3] Brenntag's main operations include food, pharmaceuticals, cosmetics, oil and gas, and water purification.

[5] Brenntag's product catalog includes more than 10,000 items ranging from acids, bases, and solvents to substances for the food, cosmetics, feed and pharmaceutical industries.

At issue is the supply of raw materials for painkillers by Brenntag's Swiss-based subsidiary to the Syrian company MPI.